歡迎光臨~杭州紐羅西敏生物科技有限公司
  咨詢電話:0571-88254427

行業新聞及文獻

A Sanger sequencing protocol for SARS-CoV-2 S-gene

We describe a Sanger sequencing protocol for SARS-CoV-2 S-gene the Spike (S)-glycoprotein product of which, composed of receptor-binding (S1) and membrane fusion (S2) segments, is the target of vaccines used to combat COVID-19. The protocol can be used in laboratories with basic Sanger sequencing capabilities and allows rapid "at source" screening for SARS-CoV-2 variants, notably those of concern. The protocol has been applied for surveillance, with clinical specimens collected in either nucleic acid preservation lysis-mix or virus transport medium, and research involving cultured viruses, and can yield data of public health importance in a timely manner.

聯系我們

聯系人:

手 機:0571-88254427

郵 箱:info@neuro-hemin.com

公 司:杭州紐羅西敏生物科技有限公司

地 址:杭州市教工路316號

jealousvue日本成熟50maof